Gonadocorticoid exposure is associated with increased odds of lichen planopilaris and frontal fibrosing alopecia: A large retrospective cohort study - 15/11/24
Doi : 10.1016/j.jaad.2024.10.030
Amit Singal, BA a, Michael M. Ong, BS b, Shari R. Lipner, MD, PhD c, ⁎ 
a Rutgers New Jersey Medical School, Newark, New Jersey
b MD Program, Weill Cornell Medical College, New York, New York
c Department of Dermatology, Weill Cornell Medicine, New York, New York
∗Correspondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Ave 9th Floor, New York, NY 10021Department of DermatologyWeill Cornell Medicine1305 York Ave 9th FloorNew YorkNY10021
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Friday 15 November 2024
Key words : frontal fibrosing alopecia, gonadocorticoids, risk factors, sex hormones
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
|
| Ethical considerations: This retrospective study is exempt from informed consent. The data reviewed is a secondary analysis of existing data, does not involve intervention or interaction with human subjects, and is de-identified per the de-identification standard defined in Section §164.514(a) of the HIPAA Privacy Rule. The process by which the data is de-identified is attested to through a formal determination by a qualified expert as defined in Section §164.514(b) (1) of the HIPAA Privacy Rule. This formal determination by a qualified expert refreshed on December 2020. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?